Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/11/931
Active ingredient: Plerixafor
Indication: Adjunctive treatment to cytotoxic therapy in acute myeloid leukaemia
Sponsor: Genzyme Europe B.V.
Gooimeer 10, 1411 DD Naarden, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/12/2011 Orphan designation EMA/OD/074/11 (2011)9417 of 09/12/2011
18/09/2014 Removal of orphan designation from Community Register